The Impact of Frailty on Cardiopulmonary Resuscitation Adverse Outcomes in Patients Requiring Code Blue Activation
1 other identifier
observational
2
1 country
2
Brief Summary
The aim of this study was to determine the independent association of frailty with cardiopulmonary resuscitation and predictive factors in patients triggering code blue response
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2025
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 29, 2023
CompletedFirst Posted
Study publicly available on registry
May 8, 2024
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2026
ExpectedNovember 19, 2025
November 1, 2025
5 months
December 29, 2023
November 16, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
code blue reason
comorbid disease and dog usage
years
duration of CPR time
between the time of giving the blue code and the end of CPR
hours
Secondary Outcomes (2)
the airway equipment used
days
mortality and morbidity
mounts
Study Arms (2)
Edmonton frailty scale ≥ 7
The frailty status of the patients will be assessed using the Edmonton frailty scale. According to the Edmonton frailty scale; * (0-5): not frail * (6-7): sensitive * (8-9): slightly fragile * (10-11): moderately fragile, * (12-17): extremely fragile
Edmonton frailty scale below 7
The frailty status of the patients will be assessed using the Edmonton frailty scale. According to the Edmonton frailty scale; * (0-5): not frail * (6-7): sensitive * (8-9): slightly fragile * (10-11): moderately fragile, * (12-17): extremely fragile
Interventions
The frailty status of the patients will be assessed using the Edmonton frailty scale. According to the Edmonton frailty scale; * (0-5): not frail * (6-7): sensitive * (8-9): slightly fragile * (10-11): moderately fragile, * (12-17): extremely fragile
Eligibility Criteria
Adult patients with hospitalization and those who are not inpatients (in the outpatient clinic system) requiring Code Blue will be included in the study.
You may qualify if:
- pediatric patients
You may not qualify if:
- pregnant patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Umraniye Education and Research Hospital
Istanbul, Umraniye, 34734, Turkey (Türkiye)
Umraniye Education and Research Hospital
Istanbul, Umraniye, 34734, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Anesthesiology and Reanimation department,Assoc Prof
Study Record Dates
First Submitted
December 29, 2023
First Posted
May 8, 2024
Study Start
December 1, 2025
Primary Completion
April 30, 2026
Study Completion (Estimated)
May 30, 2026
Last Updated
November 19, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share